HOPE:NASDAQHope Bancorp, Inc. Analysis
Data as of 2026-06-17 - not real-time
$13.04
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Hope Bancorp is trading at $13.04, comfortably above its 20‑day SMA of 12.61 and 50‑day SMA of 12.45, confirming a bullish short‑term trend. The MACD histogram is positive (0.055) and the RSI sits at 62.5, indicating momentum without being overbought, while the price sits near the identified support of 12.01 and below the resistance of 13.29, suggesting room for upside. Valuation metrics show a trailing P/E of 23.7 versus an industry average of 17.1, yet the DCF‑derived fair value of $24.47 implies a potential 10% upside from current levels. The bank boasts a robust cash position of $630 M against $489 M of debt, a low beta of 0.93, and a 30‑day volatility of 21.6%, supporting a moderate risk profile. Dividend yield is attractive at 4.29% but the payout ratio exceeds 100%, raising questions about sustainability. Overall, the combination of solid earnings growth, strong liquidity, and technical strength points to a cautiously optimistic outlook for investors.
The regional banking sector faces medium‑level regulatory and credit‑cycle risks, which temper the upside despite the favorable technical setup. While the forward P/E of 8.1 suggests earnings are expected to improve, the high dividend payout and a modest ROE of 3.15% warrant a measured approach. Investors should monitor loan‑quality trends and any shifts in monetary policy that could impact net interest margins. Given the current price relative to DCF valuation and the supportive technical indicators, a short‑to‑medium‑term buying opportunity exists, but prudent position sizing is advised.
The regional banking sector faces medium‑level regulatory and credit‑cycle risks, which temper the upside despite the favorable technical setup. While the forward P/E of 8.1 suggests earnings are expected to improve, the high dividend payout and a modest ROE of 3.15% warrant a measured approach. Investors should monitor loan‑quality trends and any shifts in monetary policy that could impact net interest margins. Given the current price relative to DCF valuation and the supportive technical indicators, a short‑to‑medium‑term buying opportunity exists, but prudent position sizing is advised.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical indicators (price above SMA20/50, positive MACD)
- Proximity to support with upside to resistance
- DCF valuation indicating ~10% upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong cash position relative to debt
- Forward earnings growth implied by low forward P/E
- Attractive dividend yield despite sustainability concerns
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Medium regulatory and credit‑cycle risk in regional banking
- High payout ratio may pressure dividend sustainability
- Stable beta and moderate volatility supporting defensive profile
Key Metrics & Analysis
Financial Health
Revenue Growth18.40%
Profit Margin14.70%
P/E Ratio23.7
ROE3.15%
ROA0.39%
P/B Ratio0.7
Op. Cash Flow$151.7M
Industry P/E17.1
Technical Analysis
TrendBullish
RSI62.5
Support$12.01
Resistance$13.29
MA 20$12.61
MA 50$12.45
MA 200$11.46
MACDBullish
VolumeStable
Fear & Greed Index92.13
Valuation
Fair Value$24.47
Target Price$14.38
Upside/Downside10.24%
GradeUndervalued
TypeBlend
Dividend Yield4.29%
Risk Assessment
Beta0.93
Volatility21.60%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.